A Multicenter Randomized Open-Label Trial Evaluating MRD-Guided Interruption Versus Standard of Care Immune-Checkpoint Inhibitor (ICI) Therapy In Patients With Advanced / Metastatic Solid Tumors.
1d agoen
From the article
Conditions : NSCLC (Advanced Non-small Cell Lung Cancer); NSCLC (Non-small Cell Lung Cancer); NSCLC (Non-small Cell Lung Carcinoma); NSCLC; Melanoma (Skin Cancer); Melanoma (Skin) Stage IV; CRC; MSI High Colorectal Cancer; DMMR Colorectal Cancer; RCC, Renal Cell Cancer; RCC; Solid Tumors; Metastatic Solid Tumors; Advanced Solid Tumors; Advanced Solid Tumors Cancer Interventions : Device: Signatera Genome ultra-sensitive ctDNA blood test Sponsors : Natera, Inc. Not yet recruiting
Continue reading on clinicaltrials.govYou might also wanna read
Study uses brain's glymphatic system to deliver gene therapy across blood-brain barrier
A new study presents a gene therapy strategy that leverages the brain's glymphatic transport system to deliver engineered adeno-associated v

Blood-brain barrier-like vascular gate identified as key driver of immunotherapy resistance in small cell lung cancer
Researchers have identified a blood-brain barrier-like vascular gate (BVG) in small cell lung cancer (SCLC) and other neuroendocrine cancers
cell.com·4h ago

STAT+: RFK Jr. plans to create list of injuries caused by Covid-19 vaccines
STAT·5h ago

STAT+: White House reviewing top contenders to lead FDA
STAT·7h ago
AI-ECG Models Show Promise for Detecting Structural Heart Disease and Predicting Risk
AI-enabled ECG (AI-ECG) models that detect systolic and diastolic dysfunction can identify patients with structural heart disease (SHD) who
USC Study: AI Therapists Show Strong Communication Skills but Raise Safety Concerns
A USC Viterbi School of Engineering study found that AI large language models (LLMs) show strong performance in general mental health commun
dailycaller.com·8h ago

Comments
Sign in to join the conversation.
No comments yet. Be the first.